908 Devices awarded $11.5 million for detection development
These devices will use the company's High-Pressure Mass Spectrometry (HPMS) technology. Under the contract, gas chromatography will be integrated with HPMS to create a device that can provide improved detection capabilities for a wide spectrum of chemical agents.
“We are honored to receive this contract from DTRA and support their mission to better equip our U.S. warfighters with improved threat detection capabilities,” 908 Devices President and CEO Kevin Knopp said. “Today’s responders are faced with a wider array of threats than ever before, and as the mission expands, so must the toolkit. We believe the development of new product variants based on our core HPMS technology platform will play a key role in the future of threat detection and strengthen mission support.”
The DTRA aims to aid and finance the development of improved capabilities in defensive and detection devices and technology that will better protect the armed forces against weapons that are of chemical, biological, radiological, nuclear or explosive in nature.
According to the company, the integration of gas chromatography separation with HPMS will lead to a significant breakthrough in the development of enhanced analytical capabilities that will likely have multiple uses in multiple markets relating to defense and security.